A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation

PHASE2CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

June 30, 2008

Conditions
Pediculus Humanus CapitisHead Lice
Interventions
DRUG

Placebo

Vehicle Only

DRUG

BGC20-0582

BGC20-0582 is a topical gel formulation of a naturally derived product. Subjects are treated either once (day 1) or twice (day 1 and 7) with either placebo or BGC20-0582 at one of the three concentrations. Following application of the BGC20-0582 lice treatment gel of placebo the product is rinsed from the subjects hair.

Trial Locations (1)

33034

Global Health Associates of Miami Inc, Florida City

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY